Individual dopamine midbrain neurons: Functional diversity and flexibility in health and disease

Brain Research Reviews

Volumn 58, Issue 2, 2008, Pages 314-321

  Liss, Birgit ^a   Roeper, Jochen ^b  

^a UNIVERSITY OF ULM   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Differential vulnerability; Dopaminergic neuron; Functional identity; Mesocorticolimbic system; Mesostriatal projection; Pacemaker

Indexed keywords

DIHYDROPYRIDINE DERIVATIVE; SULFONYLUREA;

AMYGDALOID NUCLEUS; BIODIVERSITY; CELL DEATH; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MESENCEPHALON; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW;

ANIMALS; BRAIN DISEASES; DOPAMINE; HUMANS; MESENCEPHALON; MODELS, BIOLOGICAL; NEURONAL PLASTICITY; NEURONS;

EID: 49449099337     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2007.10.004     Document Type: Review

References (48)

1. Bean B.P. The action potential in mammalian central neurons. Nat. Rev., Neurosci. 8 (2007) 451-465
2. Beckstead M.J., Grandy D.K., Wickman K., and Williams J.T. Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 42 (2004) 939-946
3. Bjorklund A., and Dunnett S.B. Dopamine neuron systems in the brain: an update. Trends Neurosci. 30 (2007) 194-202
4. Bjorklund A., and Dunnett S.B. Fifty years of dopamine research. Trends Neurosci. 30 (2007) 185-187
5. Chan C.S., Guzman J.N., Ilijic E., Mercer J.N., Rick C., Tkatch T., Meredith G.E., and Surmeier D.J. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447 (2007) 1081-1086
6. Chiodo L.A., Bannon M.J., Grace A.A., Roth R.H., and Bunney B.S. Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience 12 (1984) 1-16
7. Chung C.Y., Seo H., Sonntag K.C., Brooks A., Lin L., and Isacson O. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum. Mol. Genet. 14 (2005) 1709-1725
8. Cragg S.J. Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. J. Neurosci. 23 (2003) 4378-4385
9. Damier P., Hirsch E.C., Agid Y., and Graybiel A.M. The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122 Pt 8 (1999) 1437-1448
10. Davis G.W. Homeostatic control of neural activity: from phenomenology to molecular design. Annu. Rev. Neurosci. (2006)
11. Deutch A.Y., and Winder D.G. A channel to neurodegeneration. Nat. Med. 12 (2006) 17-18
12. h) in central neurons. Eur. J. Neurosci. 12 (2000) 2685-2693
13. Gariano R.F., Sawyer S.F., Tepper J.M., Young S.J., and Groves P.M. Mesocortical dopaminergic neurons: 2. Electrophysiological consequences of terminal autoreceptor activation. Brain Res. Bull. 22 (1989) 517-523
14. Grace A.A., and Bunney B.S. Nigral dopamine neurons: intracellular recording and identification with l-dopa injection and histofluorescence. Science 210 (1980) 654-656
15. Grace A.A., and Bunney B.S. The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4 (1984) 2877-2890
16. Grace A.A., and Bunney B.S. The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 4 (1984) 2866-2876
17. Grace A.A., Floresco S.B., Goto Y., and Lodge D.J. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci. 30 (2007) 220-227
18. Greene J.G., Dingledine R., and Greenamyre J.T. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism. Neurobiol. Dis. 18 (2005) 19-31
19. Grimm J., Mueller A., Hefti F., and Rosenthal A. Molecular basis for catecholaminergic neuron diversity. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13891-13896
20. Haber S.N. The primate basal ganglia: parallel and integrative networks. J. Chem. Neuroanat. 26 (2003) 317-330
21. + channel-mediated dampening of dopamine neuron excitability by the antipsychotic drug haloperidol. J. Neurosci. 23 (2003) 10859-10866
22. 2 autoreceptors chronically enhance dopamine neuron pacemaker activity. J. Neurosci. 26 (2006) 5240-5247
23. + channel ligands alter the firing pattern of dopamine-containing neurons in vivo. Neuroscience 140 (2006) 623-633
24. Kamme F., and Erlander M.G. Global gene expression analysis of single cells. Curr. Opin. Drug Discov. Devel. 6 (2003) 231-236
25. 2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49 (2006) 603-615
26. Korotkova T.M., Ponomarenko A.A., Brown R.E., and Haas H.L. Functional diversity of ventral midbrain dopamine and GABAergic neurons. Mol. Neurobiol. 29 (2004) 243-259
27. Kuznetsov A.S., Kopell N.J., and Wilson C.J. Transient high-frequency firing in a coupled-oscillator model of the mesencephalic dopaminergic neuron. J. Neurophysiol. 95 (2006) 932-947
28. Liss B., and Roeper J. Correlating function and gene expression of individual basal ganglia neurons. Trends Neurosci. 27 (2004) 475-481
29. Liss B., Franz O., Sewing S., Bruns R., Neuhoff H., and Roeper J. Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription. EMBO J. 20 (2001) 5715-5724
30. Liss B., Haeckel O., Wildmann J., Miki T., Seino S., and Roeper J. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat. Neurosci. 8 (2005) 1742-1751
31. Liu Q.S., Pu L., and Poo M.M. Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 437 (2005) 1027-1031
32. Marinelli M., and White F.J. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J. Neurosci. 20 (2000) 8876-8885
33. Michel P.P., Ruberg M., and Hirsch E. Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease?. Sci. STKE 2006 (2006) e19
34. Neuhoff H., Neu A., Liss B., and Roeper J. I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J. Neurosci. 22 (2002) 1290-1302
35. Puopolo M., Raviola E., and Bean B.P. Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons. J. Neurosci. 27 (2007) 645-656
36. Robinson S., Smith D.M., Mizumori S.J., and Palmiter R.D. Firing properties of dopamine neurons in freely moving dopamine-deficient mice: effects of dopamine receptor activation and anesthesia. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13329-13334
37. Salthun-Lassalle B., Hirsch E.C., Wolfart J., Ruberg M., and Michel P.P. Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J. Neurosci. 24 (2004) 5922-5930
38. Schultz W. Behavioral dopamine signals. Trends Neurosci. 30 (2007) 203-210
39. Schultz W. Multiple dopamine functions at different time courses. Annu. Rev. Neurosci. 30 (2007) 259-288
40. Schulz D.J., Baines R.A., Hempel C.M., Li L., Liss B., and Misonou H. Cellular excitability and the regulation of functional neuronal identity: from gene expression to neuromodulation. J. Neurosci. 26 (2006) 10362-10367
41. h on the firing of a subgroup of midbrain dopamine neurons. NeuroReport 12 (2001) 255-258
42. Stefani M.R., and Moghaddam B. Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum. J. Neurosci. 26 (2006) 8810-8818
43. Sulzer D. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci. 30 (2007) 244-250
44. Sulzer D., and Schmitz Y. Parkinson's disease: return of an old prime suspect. Neuron 55 (2007) 8-10
45. Ungless M.A., Whistler J.L., Malenka R.C., and Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411 (2001) 583-587
46. Williams-Gray C.H., Hampshire A., Robbins T.W., Owen A.M., and Barker R.A. Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J. Neurosci. 27 (2007) 4832-4838
47. Wolfart J., Neuhoff H., Franz O., and Roeper J. Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J. Neurosci. 21 (2001) 3443-3456
48. Zolles G., Klocker N., Wenzel D., Weisser-Thomas J., Fleischmann B.K., Roeper J., and Fakler B. Pacemaking by HCN channels requires interaction with phosphoinositides. Neuron 52 (2006) 1027-1036